1. Hayeh SS. The optic nerve circulation in health and disease. Exp Eye Res. 1995. 61:259–272.
2. Flammer J, Orgul S. Optic nerve blood-flow abnormalities in glaucoma. Prog Retin Eye Res. 1998. 17:267–289.
3. Bresson-Dumont H, Bechetoille A. [Role of arterial blood pressure in the development of glaucomatous lesions]. J Fr Ophtalmol. 1996. 19:435–442.
4. Cioffi GA, Sullivan P. The effect of chronic ischemia on the primate optic nerve. Eur J Ophthalmol. 1999. 9:suppl 1. S34–S36.
5. Costa VP, Harris A, Stefansson E, et al. The effects of antiglaucoma and systemic medications on ocular blood flow. Prog Retin Eye Res. 2003. 22:769–805.
6. Hafez AS, Bizzarro R, Descovich D, Lesk MR. Correlation between finger blood flow and changes in optic nerve head blood flow following therapeutic intraocular pressure reduction. J Glaucoma. 2005. 14:448–454.
7. Phelps CD, Corbett JJ. Migraine and low-tension glaucoma. A case-control study. Invest Ophthalmol vis Sci. 1985. 26:1105–1108.
8. Morgan RW, Drance SM. Chronic open-angle glaucoma and ocular hypertension. An epidemiological study. Br J Ophthalmol. 1975. 59:211–215.
9. Broadway DC, Drance SM. Glaucoma and vasospasm. Br J Ophthalmol. 1998. 82:862–870.
10. Shimada K, Kawamoto A, Matsubayashi K, et al. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens. 1992. 10:875–878.
11. Meyer JH, Brandi-Dohrn J, Funk J. Twenty four hour blood pressure monitoring in normal tension glaucoma. Br J Ophthalmol. 1996. 80:864–867.
12. Bonomi L, Marchini G, Marraffa M, et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology. 2000. 107:1287–1293.
13. Collignon N, Dewe W, Guillaume S, Collignon-Brach J. Ambulatory blood pressure monitoring in glaucoma patients. The nocturnal systolic dip and its relationship with disease progression. Int Ophthalmol. 1998. 22:19–25.
14. Graham SL, Drance SM. Nocturnal hypotension: role in glaucoma progression. Surv Ophthalmol. 1999. 43:Suppl 1. S10–S16.
15. Liu JH. Diurnal measurement of intraocular pressure. J Glaucoma. 2001. 10:S39–S41.
16. Tsukahara S, Sasaki T. Postural change of IOP in normal persons and in patients with primary wide open-angle glaucoma and low-tension glaucoma. Br J Ophthalmol. 1984. 68:389–392.
17. Choi J, Jeong J, Cho HS, Kook MS. Effect of nocturnal blood pressure reduction on circadian fluctuation of mean ocular perfusion pressure: a risk factor for normal tension glaucoma. Invest Ophthalmol Vis Sci. 2006. 47:831–836.
18. Choi J, Kim KH, Jeong J, et al. Circadian Fluctuation of Mean zOcular Perfusion Pressure Is a Consistent Risk Factor for Normal-Tension Glaucoma. Invest Ophthalmol Vis Sci. 2007. 48:104–111.
19. Kook MS, Cho HS, Seong M, Choi J. Scanning laser polarimetry using variable corneal compensation in the detection of glaucoma with localized visual field defects. Ophthalmology. 2005. 112:1970–1978.
20. Zhou Q, Weinreb RN. Individualized compensation of anterior segment birefringence during scanning laser polarimetry. Invest Ophthalmol Vis Sci. 2002. 43:2221–2228.
21. Weinreb RN, Bowd C, Zangwill LM. Glaucoma detection using scanninglaser polarimetry with variable corneal polarization compensation. Arch Ophthalmol. 2003. 121:218–224.
22. Verdecchia P, Schillaci G, Porcellati S. Dippers versus non dippers. J Hypertens. 1991. 9:S42–S44.
23. Hayreh SS, Podhajsky P, Zimmerman MB. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica. 1999. 213:76–96.
24. Jampol LM, Board RJ, Maumenee AE. Systemic hypotension and glaucomatous changes. Am J Ophthalmol. 1978. 85:154–159.
25. Meyer JH, Brandi-Dohrn J, Funk J. Twenty four hour blood pressure monitoring in normal tension glaucoma. Br J Ophthalmol. 1996. 80:864–867.
26. Pannarale G, Pannarale L, Arrico L, et al. Ambulatory blood pressure in patients with glaucoma. Invest Ophthalmol Vis Sci. 1996. 37:S30.
27. Graham SL, Drance SM. Nocturnal hypotension: role in glaucoma progression. Surv Ophthalmol. 1999. 43:Suppl 1. S10–S16.
28. Gramer E, Tausch M. The risk profile of the glaucomatous patient. Curr Opin Ophthalmol. 1995. 6:78–88.
29. Berglund G. Goals of antihypertensive therapy, is there a point beyond which pressure reduction is dangerous? Am J Hypertens. 1989. 2:586–593.
30. Criuckshank JM, thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet. 1987. 1(8533):581–583.
31. Farnett L, Mulrow CD, Linn WD, et al. The J-curve phenomenon and the treatment of hypertension, is there a point beyond which pressre reduction is dangerous? JAMA. 1991. 265:489–495.
32. Rouhiainen HJ, Terasvorta ME. Hemodynamic variables in progressive and non-progressive low tension glaucoma. Acta Ophthalmol. 1990. 68:34–36.
33. Riccadonna M, Covi G, Pancera P, et al. Autonomic system activity and 24-hour blood pressure variations in subjects with normal- and high-tension glaucoma. J Glaucoma. 2003. 12:156–163.
34. Yazici B, Usta E, Erturk H, Dilek K. Comparison of ambulatory blood pressure values in patients with glaucoma and ocular hypertension. Eye. 2003. 17:593–598.
35. Feke GT, Pasquale LR. Retinal Blood Flow Response to Posture Change in Glaucoma Patients Compared with Healthy Subjects. Ophthalmology. 2008. 115:246–252.
36. Evans DW, Harris A, Garrett M, et al. Glaucoma patients demonstrate faulty autoregulation of ocular blood flow during posture change. Br J Ophthalmol. 1999. 83:809–813.
37. Leske MC, Heijl A, Hyman L, et al. Predictors of Long-term Progression in the early Manifest glaucoma Trial. Ophthalmology. 2007. 114:1965–1972.
38. Fuchsjager-Mayrl G, Wally B, Georgopoulos M, et al. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci. 2004. 45:834–839.
39. Grunwald JE, Piltz JR, Hariprasad SM, Dupont J, Maguire aMG. Optic nerver blood flow in glaucoma: effect of systemic hypertension. Am J Ophthalmol. 1999. 127:516–522.
40. Sugiyama T, Utsunomiya K, Ota H, et al. Comparative study of cerebral blood flow in patients with normal-tension glaucoma and control subjects. Am J Ophthalmol. 2006. 141:394–396.
41. Shimada K, Kawamoto A, Matsubayashi K, et al. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens. 1992. 10:875–878.
42. Shimada K, Kario K. Altered circadian rhythm of blood pressure and cerebrovascular damage. Blood Press Monit. 1997. 2:333–338.
43. Manabe Y, Murakami T, Iwatsuki K, et al. Nocturnal blood pressure dip in CADASIL. J Neurol Sci. 2001. 193:13–16.
44. Rufa A, Dotti MT, Franchi M, et al. Systemic blood pressure profile in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke. 2005. 36:2554–2558.
45. Aliev G, Obrenovich ME, Seyidova D, de la Torre JC. Exploring ischemia-induced vascular lesions and potential pharmacological intervention strategies. Histol Histopathol. 2005. 20:261–273.
46. Reimer KA, Tanaka M, Murry CE, et al. Evaluation of free radical injury in myocardium. Toxicol Pathol. 1990. 18:470–480.
47. Sayegh FN, Weigelin E. Functional ophthalmodynamometry: comparison between brachial and ophthalmic blood pressure in sitting and supine position. Angiology. 1983. 34:176–182.